loading page

javascript:void(0) Hepatoid adenocarcinoma of stomach with simultaneous liver and pancreatic metastases: A case report
  • +1
  • Qiliu Qian,
  • Mingyue Hu,
  • Yulin Yang,
  • Nan Li
Qiliu Qian
Southeast University School of Medicine
Author Profile
Mingyue Hu
Southeast University Zhongda Hospital
Author Profile
Yulin Yang
Southeast University Zhongda Hospital
Author Profile
Nan Li
Southeast University Zhongda Hospital

Corresponding Author:linan_0627@163.com

Author Profile

Abstract

not-yet-known not-yet-known not-yet-known unknown Background: Hepatoid adenocarcinoma (HAC) is an extrahepatic adenocarcinoma characterized by hepatoid differentiation, often associated with elevated serum alpha-fetoprotein (AFP) levels. The stomach is the most common site of HAC, and this is specifically identified by the term hepatoid adenocarcinoma of the stomach (HAS). Case: We present a case of a 71-year-old patient who was immunohistologically diagnosed with HAS along with both liver metastasis and pancreatic metastasis. Sindilizumab+ albumin paclitaxel+ 5-fluorouracil+ calcium folinate/ cyclophosphamide was started after the disagreement of surgical treatment. After 6 months treatment, both primary and metastatic lesions visibly shrank and imaging examinations did not reveal the presence of local recurrence or other distant metastasis. Conclusion: More research is still needed for HAS, especially for special cases with multiple metastases simultaneously.
28 Aug 2024Submitted to Cancer Reports
02 Sep 2024Submission Checks Completed
02 Sep 2024Assigned to Editor
02 Sep 2024Review(s) Completed, Editorial Evaluation Pending
05 Sep 2024Reviewer(s) Assigned